Dupilumab efficacy in patients with COPD and type 2 inflammation irrespective of mortality risk score

被引：0
|
作者：
Vogelmeier, Claus [1 ]
Rabe, Klaus F. [2 ]
Bhatt, Surya P. [3 ]
Hanania, Nicola A. [4 ]
Bafadhel, Mona [5 ]
Christenson, Stephanie A. [6 ]
Papi, Alberto [7 ]
Singh, Dave [8 ]
Laws, Elizabeth [9 ]
Maloney, Jennifer [9 ,10 ]
Lu, Xin [9 ]
Bauer, Deborah [9 ]
Bansal, Ashish [10 ]
Robinson, Lacey B. [11 ]
Abdulai, Raolat M. [11 ]
机构：
[1] Univ Marburg, German Ctr Lung Res DZL, Dept Med, Marburg, Germany
[2] German Ctr Lung Res, LungenClin Grosshansdorf & Christian Albrechts Uni, Airway Res Ctr North, Grosshansdorf, Germany
[3] Univ Alabama Birmingham, Div Pulm, Birmingham, AL USA
[4] Baylor Coll Med, Dept Med, Sect Pulm & Crit Care Med, Houston, TX USA
[5] Kings Coll London, Fac Life Sci & Med, Kings Ctr Lung Hlth, Sch Immunol & Microbial Sci, London, England
[6] Univ Calif San Francisco, Div Pulm, San Francisco, CA USA
[7] Univ Ferrara, Ferrara, Italy
[8] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester, England
[9] Sanofi, Bridgewater, NJ USA
[10] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[11] Sanofi, Cambridge, MA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4782
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Efficacy and Safety of Dupilumab in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: Pooled Analysis of BOREAS and NOTUS Trials
    Robinson, Lacey
    Bhatt, Surya
    Rabe, Klaus
    Hanania, Nicola
    Vogelmeier, Claus
    Bafadhel, Mona
    Christenson, Stephanie
    Papi, Alberto
    Singhphysician, Dave
    Laws, Elizabeth
    Akinlade, Bolanle
    Maloney, Jennifer
    Bansal, Ashish
    Abdulai, Raolat
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB307 - AB307
  • [22] Dupilumab efficacy in patients with GINA-defined type 2 asthma: TRAVERSE
    Bateman, Eric D.
    Pavord, Ian D.
    Busse, William W.
    Daizadeh, Nadia
    Deniz, Yamo
    Rowe, Paul
    Jacob-Nara, Juby A.
    Gall, Rebecca
    Pandit-Abid, Nami
    Ortiz, Benjamin
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [23] Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
    Bleecker, Eugene R.
    Panettieri, Reynold A.
    Lugogo, Njira L.
    Corren, Jonathan
    Daizadeh, Nadia
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Khodzhayev, Angela
    Soler, Xavier
    Ferro, Thomas J.
    Hansen, Christopher N.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2023, 2023
  • [24] COPD-Exacerbation Mortality Risk-Score confirmed
    Klein, Friederike
    PNEUMOLOGIE, 2016, 70 (09): : 560 - 560
  • [25] Correlation between systemic inflammation and cardiovascular risk in COPD patients. development of an inflammatory score
    Munoz Montiel, Ana
    Ruiz Esteban, Pedro
    Garcia Florido, Natalia
    Dona Diaz, Esperanza
    Del Rio, Adolfo Domenech
    Olveira Fuster, Casilda
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [26] Elevated Eosinophil Count Associated with Dupilumab Therapy in Patients with Type-2 Inflammation
    Klimek, Ludger
    Spielhaupter, Magdalena
    Alali, Ali
    Cichy, Marc
    Huppertz, Tilman
    Hagemann, Jan
    LARYNGO-RHINO-OTOLOGIE, 2020, 99 (11) : 811 - 812
  • [27] Type 2 airway inflammation in COPD
    Polverino, Francesca
    Sin, Don D.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (05)
  • [28] Empagliflozin reduces mortality and hospitalisation for heart failure irrespective of cardiovascular risk score at baseline
    Fitchett, D.
    Inzucchi, S. E.
    Cannon, C. P.
    McGuire, D. K.
    Johansen, O. E.
    Sambevski, S.
    Hehnke, U.
    George, J.
    Zinman, B.
    EUROPEAN HEART JOURNAL, 2018, 39 : 400 - 401
  • [29] Empagliflozin reduces mortality and hospitalisation for heart failure irrespective of cardiovascular risk score at baseline
    Fitchett, D.
    Inzucchi, S. E.
    Cannon, C. P.
    McGuire, D. K.
    Johansen, O. E.
    Sambevski, S.
    Hehnke, U.
    George, J. T.
    Zinman, B.
    DIABETOLOGIA, 2018, 61 : S57 - S57
  • [30] EFFICACY OF DUPILUMAB IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH TYPE 2 INFLAMMATION BY BASELINE BLOOD EOSINOPHIL COUNT
    Bafadhel, M.
    Bhatt, S. P.
    Rabe, K. F.
    Hanania, N. A.
    Vogelmeier, C. F.
    Cole, J.
    Christenson, S. A.
    Papi, A.
    Singh, D.
    Laws, E.
    Mortensen, E. R.
    Maloney, J.
    Lu, X.
    Bauer, D.
    Bansal, A.
    Robinson, L. B.
    Abdulai, R. M.
    THORAX, 2023, 78 (SUPPL_4) : A25 - A26
12345